Up a level |
Kearney, Anna ORCID: 0000-0003-1404-3370, Ashford, Polly-Anna, Butlin, Laura, Conway, Thomas, Cragg, William J, Devane, Declan, Gardner, Heidi, Gaunt, Daisy M, Gillies, Katie, Harman, Nicola L ORCID: 0000-0001-6958-6466 et al (show 9 more authors)
(2022)
Developing an online, searchable database to systematically map and organise current literature on retention research (ORRCA2).
CLINICAL TRIALS, 19 (1).
pp. 71-80.
Kearney, Anna ORCID: 0000-0003-1404-3370, Harman, Nicola L ORCID: 0000-0001-6958-6466, Rosala-Hallas, Anna ORCID: 0000-0001-8012-9995, Beecher, Claire, Blazeby, Jane M, Bower, Peter, Clarke, Mike, Cragg, William, Duane, Sinead, Gardner, Heidi et al (show 9 more authors)
(2018)
Development of an online resource for recruitment research in clinical trials to organise and map current literature.
CLINICAL TRIALS, 15 (6).
pp. 533-542.
Treweek, Shaun, Bevan, Simon, Bower, Peter, Campbell, Marion, Christie, Jacquie, Clarke, Mike, Collett, Clive, Cotton, Seonaidh, Devane, Declan, El Feky, Adel et al (show 14 more authors)
(2018)
Trial Forge Guidance 1: what is a Study Within A Trial (SWAT)?
TRIALS, 19 (1).
139-.
Treweek, Shaun, Bevan, Simon, Bower, Peter, Briel, Matthias, Campbell, Marion, Christie, Jacquie, Collett, Clive, Cotton, Seonaidh, Devane, Declan, El Feky, Adel et al (show 17 more authors)
(2020)
Trial Forge Guidance 2: how to decide if a further Study Within A Trial (SWAT) is needed.
Trials, 21 (1).
33-.
Brunsdon, Dan, Biesty, Linda, Brocklehurst, Peter, Brueton, Valerie, Devane, Declan, Elliott, Jim, Galvin, Sandra, Gamble, Carrol ORCID: 0000-0002-3021-1955, Gardner, Heidi, Healy, Patricia et al (show 14 more authors)
(2019)
What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study.
Trials, 20 (1).
593-.
Gillies, Katie, Williamson, Paula R ORCID: 0000-0001-9802-6636, Entwistle, Vikki A, Gardner, Heidi, Treweek, Shaun and Campbell, Marion K
(2021)
An international core outcome set for evaluating interventions to improve informed consent to clinical trials: The ELICIT Study.
JOURNAL OF CLINICAL EPIDEMIOLOGY, 137.
pp. 14-22.